{
    "title": "Rickets: Calcium, Genes, etc",
    "slug": "rickets-calcium-genes-etc",
    "aliases": [
        "/Rickets+Calcium+Genes+etc+-+Jan+2013",
        "/4263"
    ],
    "tiki_page_id": 4263,
    "date": "2013-07-01",
    "categories": [
        "Rickets",
        "Genetics"
    ],
    "tags": [
        "CYPA",
        "CYPB",
        "CYPR",
        "Genetics",
        "Rickets",
        "blood levels",
        "bone",
        "bone cancer",
        "bone mineral density",
        "cancer",
        "cancer in VDR",
        "child",
        "childhood cancer",
        "falls fractures",
        "genetics",
        "hepatitis c",
        "liver",
        "magnesium",
        "magnesium and cancer",
        "prostate cancer",
        "rickets",
        "vitamin d",
        "vitamin d binding",
        "vitamin d blood test",
        "vitamin d receptor"
    ]
}


<p>

<strong><span class="citation-abbreviation">Indian J Endocrinol Metab. </span><span class="citation-publication-date">2013 Jan-Feb; </span><span class="citation-volume">17</span><span class="citation-issue">(1)</span><span class="citation-flpages">: 1–4. </span></strong></p>

<div class="fm-citation-pmcid">

<span class="doi">doi:  <a href="http://dx.doi.org/10.4103%2F2230-8210.107789">10.4103/2230-8210.107789</a></span><span class="fm-citation-ids-label">PMCID: </span><span>PMC3659873</span></div>

<h1 class="content-title">

Rickets: Twists and turns in the Gordian knot</h1>

<div class="half_rhythm">

<div class="contrib-group fm-author">

<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Garg%20MK%5Bauth%5D">M. K. Garg</a> and <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Kalra%20S%5Bauth%5D">Sanjay Kalra</a><sup>1</sup></div>

</div>

<div class="fm-panel small half_rhythm">

<div class="fm-authors-info fm-panel half_rhythm">

<div class="fm-affl">

<em>Department of Endocrinology, Command Hospital, Southern Command, Pune, Maharashtra, India</em></div>

<div class="fm-affl">

<sup>1</sup><em>Department of Endocrinology, Bharti Hospital and B.R.I.D.E., Karnal, Haryana, India</em></div>

<div id="cor1">

<strong>Corresponding Author:</strong> Col. M. K. Garg, Department of Endocrinology, Command Hospital, Southern Command, Pune, Maharashtra, India. E-mail: <span class="e_id352731"><a href="mailto:mkgargs@gmail.com">mkgargs@gmail.com</a></span></div>

</div>

<div class="fm-cpl-info fm-panel half_rhythm">

<div class="fm-copyright half_rhythm">

<a href="http://www.ncbi.nlm.nih.gov/pmc/about/copyright.html">Copyright</a> : © Indian Journal of Endocrinology and Metabolism</div>

<div class="fm-copyright half_rhythm">

This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</div>

</div>

</div>

<div class="sec headless whole_rhythm">

<p>

Traditional scientific wisdom teaches that rickets, so plentiful in India, is caused by vitamin D deficiency and cured by vitamin D replacement. Rickets also occurs in the presence of vitamin D sufficiency, as in hypophosphatemic and hypocalcemic rickets; this, however, is not the topic of this editorial. It is still not understood why some children develop rickets, while others do not, even in the face of severe Vitamin D deficiency. This editorial tries to probe the recent twists and turns that researchers have taken while trying to unravel this Gordian knot.</p>

</div>

<div class="sec" id="sec1-1">

<div class="goto jig-ncbiinpagenav-goto-container">

</div>

<h2 class="head no_bottom_margin ui-helper-clearfix" id="sec1-1title">

N<span class="small-caps">OT AS</span> S<span class="small-caps">IMPLE AS</span> C<span class="small-caps">ALCIUM</span> I<span class="small-caps">NTAKE</span></h2>

<p>

The role of calcium deficiency on the background of vitamin D deficiency as the causation of rickets has been highlighted in a recent article by Aggarwal, <em>et al</em>.<a class="wiki external" href="" target="_blank">1</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref1">1</a> They compared 67 cases of rickets with 68 healthy controls. Among cases, serum 25-hydroxy vitamin D <a class="wiki" href="25(OH)%20D" rel="">25(OH) D</a> levels were comparable, but calcium intake, total and from diary intake was significantly lower as compared to controls. They concluded that rickets develops when low dietary calcium intake coexists with a low or borderline vitamin D nutrition status. However, they have not highlighted another interesting finding: Cases of rickets mount robust parathyroid hormone (PTH) response as compared to controls with same vitamin D levels. This was again explained by calcium deficiency which exacerbated PTH response in the presence of vitamin D deficiency. A similar observation has been made by an Indian study among elderly population, in which more than half of population did not mount PTH response in spite of severe vitamin D deficiency <a class="wiki" href="25(OH)%20D%20" rel="">25(OH) D &lt;10 ng/ml</a>.<a class="wiki external" href="" target="_blank">2</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref2">2</a> A recently published study also substantiated this observation by analyzing lab results of more than 300,000 pairs of 25(OH) D and PTH levels in a population. They also found that &gt;50% of patients do not mount PTH response.<a class="wiki external" href="" target="_blank">3</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref3">3</a> Similar observation in two different populations with different calcium intake suggests that there are other mechanisms/factors responsible for PTH response rather than calcium intake. It is also likely same mechanisms/factors may also contribute to development of rickets in patients with vitamin D deficiency rather than dietary calcium deficiency.</p>

</div>

<div class="sec" id="sec1-2">

<h2 class="head no_bottom_margin ui-helper-clearfix" id="sec1-2title">

B<span class="small-caps">IOCHEMISTRY</span> R<span class="small-caps">EVISITED</span></h2>

<p>

Endogenous vitamin D is synthesized in epidermis. Exogenously, vitamin D can be derived from vegetable and animal sources. Vitamin D is produced in the skin by a UVB-mediated, photolytic, non-enzymatic reaction that converts 7-dehydrocholesterol to pre-vitamin D<sub>3</sub>. Pre-vitamin D<sub>3</sub> undergoes a subsequent non-enzymatic, thermal isomerization conversion to vitamin D<sub>3</sub> in the skin. Vitamin D<sub>3</sub> enters circulation and gets bound to vitamin D binding protein and is taken up by liver. In the hepatic parenchyma, vitamin D<sub>3</sub> is converted by one of several cytochrome P450 (CYP2R1, CYP2D11, CYP2D25) to 25(OH) D. 25(OH) D is the most plentiful and stable metabolite of vitamin D in human serum. This 25(OH) D is filtered in renal glomerulus and internalized in proximal convoluted tubules with the help of megalin and converted to 1,25 dihydroxy vitamin D<a class="wiki" href="1,25(OH)" rel="">1,25(OH)<sub>2</sub>D</a> by mitochondrial 1-αhydroxylase (CYP27B1). This reaction requires NADPH and ferrodoxin for electron transfer during hydroxylation reaction. 1,25(OH)<sub>2</sub>D serves as a high affinity ligand for the vitamin D receptor (VDR) in target tissues where it acts to modulate expression of vitamin D-directed genes. VDR is present in most tissues and cells in body including parathyroid cells. 1,25(OH)<sub>2</sub>D is metabolized by 24-hydroxylase (CYP24A1) enzyme to relatively inactive metabolites like 24,25 dihydroxy vitamin D and calcitroic acid.<a class="wiki external" href="" target="_blank">4</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref4">4</a> Calcium sensing receptors are also present on parathyroid cells, which modulate PTH secretion by binding with divalent cations.</p>

</div>

<div class="sec" id="sec1-3">

<h2 class="head no_bottom_margin ui-helper-clearfix" id="sec1-3title">

C<span class="small-caps">ALCIUM</span> A<span class="small-caps">BSORPTION</span></h2>

<p>

Any mechanism which affects the responsiveness of parathyroid cells will modify PTH secretory response. Activated vitamin D modifies PTH secretory response. Obviously, the same mechanism will also be operative in other VDR responsive cells. Hence, we speculate that patients who mount PTH response will have a less effective protective mechanism against vitamin D deficiency and will negatively affect calcium absorption from gut. On the contrary, those with a protective mechanism will suppress the PTH response and have more efficient absorption of dietary calcium. This suggests that it is the calcium absorptive mechanism, rather than dietary calcium intake, which predisposes an individual with vitamin D deficiency to develop rickets and PTH response.</p>

</div>

<div class="sec" id="sec1-4">

<h2 class="head no_bottom_margin ui-helper-clearfix" id="sec1-4title">

G<span class="small-caps">ORDIAN</span> K<span class="small-caps">NOT:</span> G<span class="small-caps">ENETIC</span> P<span class="small-caps">OLYMORPHISM</span></h2>

<p>

What could be the underlying mechanism(s) of this absent PTH response to vitamin D deficiency? Answer to this can explain above enigma and it may lie in genetic polymorphism. There are several genes involved in vitamin D metabolism namely GC (group component), DHCR7 (7-dehydrochlesterol reductase), NADSYN1 (nicotinamide adenine dinucleotide synthetase), CYP2R1, CYP27B1, CYP24A1, and VDR gene. 25(OH) D has high heritability (28-80%)<a class="wiki external" href="" target="_blank">5</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref5">5</a> but others disagree with this.<a class="wiki external" href="" target="_blank">6</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref6">6</a></p>

</div>

<div class="sec" id="sec1-5">

<h2 class="head no_bottom_margin ui-helper-clearfix" id="sec1-5title">

T<span class="small-caps">HE</span> GC <span class="small-caps">AND</span> CYP2R1 <span class="small-caps">GENES</span></h2>

<p>

Single-nucleotide polymorphisms (SNPs) in the gene GC (rs2282679, rs4588, and rs2282679) and a non-synonymous SNP (rs7041 and rs1155563), SNP in NADSYN1/DHCR7 (rs3829251 and rs1790349), and SNP in CYP2R1 (rs2060793) have been associated with lower 25(OH) D concentrations in European and Chinese ancestry.<a class="wiki external" href="" target="_blank">7</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref8">8</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref7">7</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref8">8</a> Similar findings have been reported in Canadian adults of east Asian, but not south Asian, origin.<a class="wiki external" href="" target="_blank">9</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref9">9</a> A systemic review of various genomic studies suggested that the optimal concentrations of 25(OH) D may vary according to genotype.<a class="wiki external" href="" target="_blank">10</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref10">10</a> SNPs involved in above genetic loci may affect 25(OH) D levels but do not affect 1,25(OH)<sub>2</sub>D<a class="wiki external" href="" target="_blank">11</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref11">11</a> and are unlikely to affect its action. Moreover, animal models with knock out loci did not develop rickets and PTH response even in the presence of low 25(OH) D concentration.<a class="wiki external" href="" target="_blank">4</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref4">4</a> Hence, these SNPs will not be able to untangle the Gordian knot of rickets pathophysiology.</p>

</div>

<div class="sec" id="sec1-6">

<h2 class="head no_bottom_margin ui-helper-clearfix" id="sec1-6title">

T<span class="small-caps">HE</span> CYP27B1 <span class="small-caps">AND</span> CYP24A1 G<span class="small-caps">ENES</span></h2>

<p>

Some polymorphisms of CYP27B1 (1-αhydroxylase enzyme) may affect the efficiency of process of generating active 1,25(OH)<sub>2</sub>D. CYP27B1-1260 promoter polymorphism (rs10877012) has a substantial impact on 1,25-(OH) 2 D serum levels, with higher levels noted with AA variant than CC variant.<a class="wiki external" href="" target="_blank">12</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref12">12</a> Other studies have also reported low levels of 1,25(OH)<sub>2</sub>D with the same SNP.<a class="wiki external" href="" target="_blank">10</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref10">10</a> More evidence comes from a study of prostatic carcinoma, where one CYP27B1 tag SNP (rs3782130) and two CYP24A1 tag SNPs (rs927650 and rs2762939) were associated with adverse outcome,<a class="wiki external" href="" target="_blank">11</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref11">11</a> indicating low efficiency of 1,25(OH)<sub>2</sub>D on tissue effect.</p>

<p>

Another enzyme, CYP24A1, also plays an important role in metabolism of 25(OH) D and 1,25(OH)<sub>2</sub>D. A SNP of CYP24A1 (rs6013897) was associated with low level of 25(OH) D<a class="wiki external" href="" target="_blank">13</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref13">13</a> indicating that increased activity of this enzyme can decrease active vitamin D. A study among South Asians showed increased activity of 24 hydroxylase enzyme in cultured in skin fibroblast and its association with lower serum 25OHD.<a class="wiki external" href="" target="_blank">14</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref14">14</a> It can be hypothesized that in subjects with less efficient CYP27B1 and relatively efficient CYP24A1 system, there will less generation of active vitamin D in the face of vitamin D deficiency or SNPs described in THE above paragraph. Decreased level of active vitamin D will have decreased physiological effects. A negative 1,25(OH)<sub>2</sub>D response element is present on the promoter region of the PTH gene. Hence, decreased levels of active vitamin D will upregulate PTH gene expression and increase PTH level, simultaneously decreasing calcium absorption and explaining the rachitic Gordian Knot.</p>

</div>

<div class="sec" id="sec1-7">

<h2 class="head no_bottom_margin ui-helper-clearfix" id="sec1-7title">

I<span class="small-caps">NFLAMMATION</span></h2>

<p>

Can an internal factor other than those mentioned above be involved in the vitamin D-PTH-calcium axis? Nuclear factor kappa-B has been implicated in downregulation of CYP27B1 gene expression.<a class="wiki external" href="" target="_blank">15</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref15">15</a> Indian subjects have higher levels of inflammatory markers compared to Caucasians and Europeans.<a class="wiki external" href="" target="_blank">16</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref16">16</a> Hence, it can be speculated that those with underlying inflammatory conditions will be more predisposed to rickets with similar 25(OH) D levels. Study of inflammatory markers in the subjects with and without rickets may reveal this pathogenetic mechanism.</p>

</div>

<div class="sec" id="sec1-8">

<h2 class="head no_bottom_margin ui-helper-clearfix" id="sec1-8title">

VDR G<span class="small-caps">ENE</span> P<span class="small-caps">OLYMORPHISM</span></h2>

<p>

VDR gene polymorphism has been reported to be a determinant of bone formation and intestinal calcium absorption. Most frequently studied are three adjacent restriction fragment length polymorphisms (RFLPs) for BsmI, ApaI, and TaqI at the 3′ end of the VDR gene and one RFLP in the start codon of VDR gene—FokI. A meta-analysis revealed that the most common haplotype for the VDR gene, regardless of ethnicity, is baT, followed by BAt and bAT in Caucasians and bAT and BaT in Asians.<a class="wiki external" href="" target="_blank">17</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref17">17</a> An Indian study reported Ft, TT, and Aa as the most common polymorphism of VDR, and FTA followed by fta as common haplotype.<a class="wiki external" href="" target="_blank">18</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref18">18</a> Many studies have assessed variable number of RFLPs and its effect on bone mineral density, calcium absorption, and PTH levels. Studies from India and Turkey reported no association of any of VDR polymorphism (BsmI and FokI from India; and ApaI and TaqI from Turkey) in patients with osteomalacia or rickets,<a class="wiki external" href="" target="_blank">19</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref20">20</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref19">19</a>,<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref20">20</a> while a study from China found that FF genotype was significantly associated with vitamin D deficiency rickets.<a class="wiki external" href="" target="_blank">21</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref21">21</a> Lorentzon, <em>et al</em>. reported that ApaI genotype Aa was found to be related to higher level of PTH in healthy Caucasian girls.<a class="wiki external" href="" target="_blank">22</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref22">22</a> Another study revealed a significant association of VDR FokI with PTH levels.<a class="wiki external" href="" target="_blank">23</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref23">23</a> Marco, <em>et al</em>. reported that BB genotype (BsmI) had less severe secondary hyperparathyroidism in predialysis patients.<a class="wiki external" href="" target="_blank">24</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref24">24</a></p>

<p>

However, these polymorphisms occur in the nonfunctional region of VDR and may indicate linkage disequilibrium with other truly functional polymorphisms elsewhere in the VDR gene.<a class="wiki external" href="" target="_blank">25</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref25">25</a> Recently, a study reported functional haplotype alleles of the 5′ 1a/1e, 1b promoter region and of the 3′ untranslated region was associated with 15% lower mRNA level of VDR expression and this could impact the vitamin D signaling efficiency.<a class="wiki external" href="" target="_blank">26</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref26">26</a> Three VDR tag SNPs (rs3782905, rs7299460, and rs11168314) and one SNP in VDR (rs10735810)<a class="wiki external" href="" target="_blank">11</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref11">11</a> were associated with adverse outcome in patients with prostatic carcinoma indicating low efficiency of these receptor polymorphism.<a class="wiki external" href="" target="_blank">14</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref14">14</a> These studies indicate that VDR polymorphisms play an important role in bone and parathyroid gland behavior, leading to differential response due to a likely tissue-specific effect of the VDR response to calcitriol.<a class="wiki external" href="" target="_blank">27</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref27">27</a> Hence, in subjects with VDR polymorphisms which are less efficient, this will adversely impact osteoblastic cells and parathyroid cells, and may untie the Gordian knot.</p>

</div>

<div class="sec" id="sec1-9">

<h2 class="head no_bottom_margin ui-helper-clearfix" id="sec1-9title">

C<span class="small-caps">ALCIUM</span> S<span class="small-caps">ENSING</span> R<span class="small-caps">ECEPTOR</span></h2>

<p>

Finally, polymorphism of calcium sensing receptor which is activated at higher calcium levels will have exaggerated PTH response at lower level of calcium. The 986S polymorphism of the CASR has recently been associated with higher serum ionized calcium levels.<a class="wiki external" href="" target="_blank">28</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref28">28</a> but three other CaSR coding region polymorphisms (Ala986Ser, Arg990Gly, and Gln1011Glu) have no major influence on indices of calcium homeostasis in this female population.<a class="wiki external" href="" target="_blank">29</a>" rel="external nofollow"&gt;<a class="bibr popnode tag_hotlink tag_tooltip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659873/?report=printable#ref29">29</a> More studies are required in this area evaluating not only interaction of calcium and CaSR but other nutritional divalent cations like magnesium, which may be contributing to the Gordian knot.</p>

</div>

<div class="sec" id="sec1-10">

<h2 class="head no_bottom_margin ui-helper-clearfix" id="sec1-10title">

C<span class="small-caps">ONCLUSION</span></h2>

<p>

Rickets/osteomalacia can be termed a life style disease. All humans had ample exposure to sunlight in aboriginal days. With evolution and modernization, the population started wearing clothes, moved into indoor dwellings, air conditioned offices, and cars. Hence, there started a trend of less and less sun exposure and synthesis of vitamin D. Nature is a great healer. Possibly there occurred genetic changes to overcome this vitamin D deficiency by improving efficiency of the vitamin D–PTH–calcium system. This is reflected in genetic polymorphism. However, individuals without these protective mechanisms are predisposed to clinical disease, and will develop rickets and osteomalacia when challenged by Vitamin D deficiency. More research is needed, however, before we have clear answers to the question raised at the beginning of this editorial. And this will open the Gordian knot of differential response to 25(OH) D levels in given individuals.</p>

</div>

<div class="sec">

<h2 class="head no_bottom_margin ui-helper-clearfix">

R<span class="small-caps">EFERENCES</span></h2>

<div class="ref-list-sec sec" id="reference-list">

<div class="ref-cit-blk half_rhythm" id="ref1">

1. <span>Aggarwal V, Seth A, Aneja S, Sharma B, Sonkar P, Singh S, et al. Role of calcium deficiency in development of nutritional rickets in Indian children: A case control study. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2012;<span class="ref-vol">97</span>:3461–6.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 22893720</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref2">

2. <span>Marwaha RK, Tandon N, Garg MK, Kanwar R, Narang A, Sastry A, et al. Vitamin D status in healthy Indians aged 50 years and above. <span><span class="ref-journal">J Assoc Physicians India. </span>2011;<span class="ref-vol">59</span>:706–9.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 22616336</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref3">

3. <span>Valcour A, Blocki F, Hawkins DM, Rao SD. Effects of age and serum 25-OH-Vitamin D on serum parathyroid hormone levels. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2012</span> In Press. </span></div>

<div class="ref-cit-blk half_rhythm" id="ref4">

4. <span>Christakos S, Ajibade DV, Dhawan P, Fechner AJ, Mady LJ. Vitamin D: Metabolism. <span><span class="ref-journal">Rheum Dis Clin North Am. </span>2012;<span class="ref-vol">38</span>:1–11.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 22525839</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref5">

5. <span>Bu FX, Armas L, Lappe J, Zhou Y, Gao G, Wang HW, et al. Comprehensive association analysis of nine candidate genes with serum 25-hydroxy vitamin D levels among healthy Caucasian subjects. <span><span class="ref-journal">Hum Genet. </span>2010;<span class="ref-vol">128</span>:549–56.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 20809279</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref6">

6. <span>Berry D, Hyppönen E. Determinants of vitamin D status: Focus ongenetic variations. <span><span class="ref-journal">Curr Opin Nephrol Hypertens. </span>2011;<span class="ref-vol">20</span>:331–6.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 21654390</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref7">

7. <span>Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, et al. Genome-wide association study of circulating vitamin D levels. <span><span class="ref-journal">Hum Mol Genet. </span>2010;<span class="ref-vol">19</span>:2739–45.</span> <span class="nowrap ref pmc"><a class="wiki" rel="">PMCID: PMC2883344</a></span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 20418485</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref8">

8. <span>Lu L, Sheng H, Li H, Gan W, Liu C, Zhu J, et al. Associations between common variants in GC and DHCR7/NADSYN1 and vitamin D concentration in Chinese Hans. <span><span class="ref-journal">Hum Genet. </span>2012;<span class="ref-vol">131</span>:505–12.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 21972121</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref9">

9. <span>Gozdzik A, Zhu J, Wong BY, Fu L, Cole DE, Parra EJ. Association of vitamin D binding protein (VDBP) polymorphisms and serum 25(OH) D concentrations in a sample of young Canadian adults of different ancestry. <span><span class="ref-journal">J Steroid Biochem Mol Biol. </span>2011;<span class="ref-vol">127</span>:405–12.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 21684333</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref10">

10. <span>McGrath JJ, Saha S, Burne TH, Eyles DW. A systematic review of the association between common single nucleotide polymorphisms and 25-hydroxyvitamin D concentrations. <span><span class="ref-journal">J Steroid Biochem Mol Biol. </span>2010;<span class="ref-vol">121</span>:471–7.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 20363324</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref11">

11. <span>Ahn J, Albanes D, Berndt SI, Peters U, Chatterjee N, Freedman ND. Prostate, Lung, Colorectal and Ovarian Trial Project Team. Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. <span><span class="ref-journal">Carcinogenesis. </span>2009;<span class="ref-vol">30</span>:769–76.</span> <span class="nowrap ref pmc"><a class="wiki" rel="">PMCID: PMC2675652</a></span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 19255064</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref12">

12. <span>Lange CM, Bojunga J, Ramos-Lopez E, von Wagner M, Hassler A, Vermehren J, et al. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. <span><span class="ref-journal">J Hepatol. </span>2011;<span class="ref-vol">54</span>:887–93.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 21145801</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref13">

13. <span>Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, et al. Common genetic determinants of vitamin D insufficiency: A genome-wide association study. <span><span class="ref-journal">Lancet. </span>2010;<span class="ref-vol">376</span>:180–8.</span> <span class="nowrap ref pmc"><a class="wiki" rel="">PMCID: PMC3086761</a></span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 20541252</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref14">

14. <span>Awumey EM, Mitra DA, Hollis BW, Kumar R, Bell NH. Vitamin D metabolism is altered in Asian Indians in the southern United States: A clinical research center study. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>1998;<span class="ref-vol">83</span>:169–73.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 9435436</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref15">

15. <span>Ebert R, Jovanovic M, Ulmer M, Schneider D, Meissner-Weigl J, Adamski J, et al. Down-regulation by nuclear factor kappaB of human 25-hydroxyvitamin D3 1alpha-hydroxylasepromoter. <span><span class="ref-journal">Mol Endocrinol. </span>2004;<span class="ref-vol">18</span>:2440–50.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 15243130</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref16">

16. <span>Yajnik CS, Joglekar CV, Lubree HG, Rege SS, Naik SS, Bhat DS, et al. Adiposity, inflammation and hyperglycaemia in rural and urban Indian men: Coronary risk of insulin sensitivity in Indian subjects (CRISIS) study. <span><span class="ref-journal">Diabetologia. </span>2008;<span class="ref-vol">51</span>:39–46.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 17972060</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref17">

17. <span>Thakkinstian A, D’Este C, Attia J. Haplotype analysis of VDR gene polymorphisms: A meta-analysis. <span><span class="ref-journal">Osteoporos Int. </span>2004;<span class="ref-vol">15</span>:729–34.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 15057510</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref18">

18. <span>Bid HK, Mishra DK, Mittal RD. Vitamin-Dreceptor (VDR) gene (Fok-I, Taq-I and Apa-I) polymorphisms in healthy individuals from north Indian population. <span><span class="ref-journal">Asian Pac J Cancer Prev. </span>2005;<span class="ref-vol">6</span>:147–52.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 16101324</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref19">

19. <span>Ray D, Goswami R, Gupta N, Tomar N, Singh N, Sreenivas V. Predisposition to vitamin D deficiency osteomalacia and rickets in females is linked to their 25(OH) D and calcium intake rather than vitamin D receptor gene polymorphism. <span><span class="ref-journal">Clin Endocrinol (Oxf) </span>2009;<span class="ref-vol">71</span>:334–40.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 19094076</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref20">

20. <span>Ak DG, Kahraman H, Dursun E, Duman BS, Erensoy N, Alagöl F, et al. Polymorphisms at the ligand binding site of the vitamin D receptor gene and osteomalacia. <span><span class="ref-journal">Dis Markers. </span>2005;<span class="ref-vol">21</span>:191–7.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 16403954</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref21">

21. <span>Lu HJ, Li HL, Hao P, Li JM, Zhou LF. Association of the vitamin D receptor gene start codon polymorphism with vitamin D deficiency rickets. <span><span class="ref-journal">Zhonghua Er Ke Za Zhi. </span>2003;<span class="ref-vol">41</span>:493–6.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 14746673</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref22">

22. <span>Lorentzon M, Lorentzon R, Nordström P. Vitamin D receptor gene polymorphism is related to bone density, circulating osteocalcin, and parathyroid hormone in healthy adolescent girls. <span><span class="ref-journal">J Bone Miner Metab. </span>2001;<span class="ref-vol">19</span>:302–7.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 11498732</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref23">

23. <span>Laaksonen MM, Outila TA, Karkkainen MU, Kemi VE, Rita HJ, Perola M, et al. Associations of vitamin D receptor, calcium-sensing receptor and parathyroid hormone gene polymorphisms with calcium homeostasis and peripheral bone density in adult Finns. <span><span class="ref-journal">J Nutrigenet Nutrigenomics. </span>2009;<span class="ref-vol">2</span>:55–63.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 19690432</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref24">

24. <span>Marco MP, Martínez I, Amoedo ML, Borràs M, Saracho R, Almirall J, et al. Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patients. <span><span class="ref-journal">Kidney Int. </span>1999;<span class="ref-vol">56</span>:1349–53.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 10504487</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref25">

25. <span>Uitterlinden AG, Fang Y, van Meurs JB, van Leeuwen H, Pols HA. Vitamin D receptor gene polymorphisms in relation to Vitamin D related disease states. <span><span class="ref-journal">J Steroid Biochem Mol Biol. </span>2004;<span class="ref-vol">89-90</span>:187–93.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 15225770</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref26">

26. <span>Fang Y, van Meurs JB, D'Alesio A, Jhamai M, Zhao H, Rivadeneira F, et al. Promoter and 3′-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: The rotterdam study. <span><span class="ref-journal">Am J Hum Genet. </span>2005;<span class="ref-vol">77</span>:807–23.</span> <span class="nowrap ref pmc"><a class="wiki" rel="">PMCID: PMC1271389</a></span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 16252240</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref27">

27. <span>Alvarez-Hernandez D, Naves-Diaz M, Gomez-Alonso C, Coto E, Cannata-Andia JB. Tissue-specific effect of VDR gene polymorphisms on the response to calcitriol. <span><span class="ref-journal">J Nephrol. </span>2008;<span class="ref-vol">21</span>:843–9.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 19034868</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref28">

28. <span>Lorentzon M, Lorentzon R, Lerner UH, Nordström P. Calcium sensing receptor gene polymorphism, circulating calcium concentrations and bone mineral density in healthy adolescent girls. <span><span class="ref-journal">Eur J Endocrinol. </span>2001;<span class="ref-vol">144</span>:257–61.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 11248745</a></span></span></div>

<div class="ref-cit-blk half_rhythm" id="ref29">

29. <span>Harding B, Curley AJ, Hannan FM, Christie PT, Bowl MR, Turner JJ, et al. Functional characterization of calcium sensing receptor polymorphisms and absence of association with indices of calcium homeostasis and bone mineral density. <span><span class="ref-journal">Clin Endocrinol (Oxf) </span>2006;<span class="ref-vol">65</span>:598–605.</span> <span class="nowrap ref pubmed"><a class="wiki" rel="">PubMed: 17054460</a></span></span></div>

</div>

</div>